Table 4.
Comparison of the outcome between chronic migraine and episodic migraine: CM 23 subjects, EM 60 subjects.
| CM | EM | |
|---|---|---|
| Migraine days/4w | ||
| 12 weeks after/baseline | 0.90 ± 0.70 | 1.06 ± 1.13 |
| P-value | 0.543 | |
| Migraine attacks/4w | ||
| 12 weeks after/ baseline | 0.75 ± 0.38 | 0.96 ± 0.70 |
| P-value | 0.173 | |
| Headache days/4w | ||
| 12 weeks after/ baseline | 0.89 ± 0.43 | 0.99 ± 0.76 |
| P-value | 0.552 | |
| Acute anti-migraine drug intake/4w | ||
| 12 weeks after/ baseline | 0.85 ± 0.65 | 0.96 ± 0.46 |
| P-value | 0.406 | |
| Severity of headache (NRS) | ||
| 12 weeks after/ baseline | 1.01 ± 0.27 | 0.97 ± 0.28 |
| P-value | 0.555 | |
CM: chronic migraine, EM: episodic migraine.